Measures of total free radical activity in critically ill patients

Clinical Biochemistry

Volumn 32, Issue 4, 1999, Pages 263-268

  MacKinnon, Kathryn L ^a   Molnar, Zsolt ^a   Lowe, Derek ^a   Watson, Ian D ^a   Shearer, Euan ^a  

^a UNIVERSITY HOSPITAL AINTREE   (United Kingdom)

Author keywords

Antioxidant gap; Multiple system organ failure; Renal failure; Sepsis; Total antioxidant status; Uric acid

Indexed keywords

FREE RADICAL; URIC ACID;

ADULT; AGED; ANTIOXIDANT ACTIVITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CRITICAL ILLNESS; HUMAN; KIDNEY FAILURE; OXIDATIVE STRESS; PRIORITY JOURNAL; URIC ACID URINE LEVEL; URINE VOLUME;

ADULT; AGED; ANTIOXIDANTS; CRITICAL ILLNESS; FREE RADICALS; HUMANS; INTENSIVE CARE UNITS; KIDNEY FAILURE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); SURVIVAL ANALYSIS; URIC ACID;

EID: 0032818315     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9120(98)00109-X     Document Type: Article

References (26)

1. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med. 20:1992;864-874.
2. Borrelli E., Lombard P.R., Grau G.E., et al. Plasma concentrations of cytokines, their soluble receptors, and antioxidant vitamins can predict the development of multiple organ failure in patients at risk. Crit Care Med. 24:1996;392-397.
3. Leff J.A., Parsons P.E., Day C.E., et al. Serum antioxidants as predictors of adult respiratory distress syndrome in patients with sepsis. Lancet. 341:1993;777-780.
4. Peake S.L., Moran J.L., Leppard P.I. N-acetyl-L-cysteine depresses cardiac performance in patients in septic shock. Crit Care Med. 24:1996;1302-1310.
5. Goode H.F., Cowley H.C., Walker B.E., Howdle P.D., Webster N.R. Decreased antioxidant status and increased lipid peroxidation in patients with septic shock and secondary organ dysfunction. Crit Care Med. 23:1995;646-651.
6. Cowley H.C., Bacon P.J., Goode H.F., Webster N.R., Jones J.G., Menon D.K. Plasma antioxidant potential in severe sepsis a comparison of survivors and non-survivors . Crit Care Med. 24:1996;1179-1183.
7. Maxwell S.R.J. Prospects for the use of antioxidant therapies. Drugs. 49:1995;345-361.
8. Wayner D.D.M., Burton G.W., Ingard K.U., Barclay L.R.C., Locke S.J. The relative contributions of vitamin E, urate, ascorbate and proteins to the total peroxyl radical trapping antioxidant activity of human blood and plasma. Biochim Biophys Acta. 924:1987;408-419.
9. Miller N.J., Rice-Evans C., Davies M.J., Gopinathan V., Milner A. A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Clin Sci. 84:1993;407-412.
10. Ogilvie A.C., Groeneveld A.B.J., Straub J.P., Thijs L.G. Plasma lipid peroxides and antioxidants in human septic shock. Intensive Care Med. 17:1991;40-44.
11. Ryan M., Grayson L., Clarke D.J. The total antioxidant capacity of human serum measured by enhanced chemiluminescence is almost completely accounted for by urate. Ann Clin Biochem. 34:1997;688-689.
12. Whitehead T.P., Thorpe G.H.G., Maxwell S.R.J. Enhanced chemiluminescent assay for antioxidant capacity in biological fluids. Anal Chim Acta. 266:1992;265-277.
13. Knaus A., Draper E.A., Wagner D.P., Zimmerman J.E. APACHE II A severity of disease classification system . Crit Care Med. 13:1985;818-829.
14. Marshall J.C., Cook D.J., Christou N.V., Bernard G.R., Spring C.L., Sibbald W.J. Multiple organ dysfunction score a reliable descriptor of a complex clinical outcome . Crit Care Med. 23:1995;1638-1652.
15. Fossati P., Prencipe L., Berti G. Use of 3,5-dichloro-2-hydroxybenzenesulfonic acid/4-aminophenazone chromogenic system in the direct enzymatic assay of uric acid in serum and urine. Clin Chem. 26:1980;227-231.
16. He X.M., Carter D.C. Atomic structure and chemistry of human serum albumin. Nature. 358:1992;209-215.
17. Miller N.J., Johnston J.D., Collis C.S., Rice-Evans C. Serum total antioxidant activity after myocardial infarction. Ann Clin Biochem. 34:1997;85-90.
18. Goode H.F., Webster N.R. Free radicals and antioxidants in sepsis. Crit Care Med. 21:1993;1770-1776.
19. Benzie I.F.F., Strain J.J. Uric acid friend or foe? Redox report. 2:1996;231-234.
20. Becker B.F. Towards the physiological function of uric acid. Free Radic Biol Med. 14:1993;615-631.
21. Brivet F.G., Kleinknecht D.J., Loirat P., Landais P.J.M. Acute renal failure in intensive care units-causes, outcome and prognostic factors of hospital mortality a prospective, multicentre study . Crit Care Med. 24:1996;192-198.
22. Jackson P., Loughrey C.M., Lightbody J.H., McNamee P.T., Young I.S. Effect of haemodialysis on total antioxidant capacity and serum antioxidants in patients with chronic renal failure. Clin Chem. 41:1995;1135-1138.
23. Mimic-Oka J., Simic T., Ekmescic V., Dragicevic P. Erythrocyte glutathione peroxidase and superoxide dismutase activities in different stages of chronic renal failure. Clin Nephrol. 44:1995;44-48.
24. Schofield D., Braganza J.M. Shortcomings of an automated assay for total antioxidant status in biological fluids. Clin Chem. 42:1996;1712-1714.
25. Johnston J.D., Miller N.J. Temporal changes of serum antioxidant concentration in a patient with diabetic ketoacidosis. Clin Chem. 44:1998;2217-2218.
26. Rumley A.G., Paterson J.R. Analytical aspects of antioxidants and free radical activity in clinical biochemistry. Ann Clin Biochem. 35:1998;181-200.